efavirenz efv sold brand names sustiva among others antiretroviral medication used treat prevent generally recommended use may used prevention needlestick injury potential sold combination taken common side effects include rash nausea headache feeling tired trouble rashes may serious serious side effects include depression thoughts suicide liver problems safe use nonnucleoside reverse transcriptase inhibitor nnrti works blocking function reverse efavirenz approved medical use united states european union world health organizations list essential available generic hiv infection previously treated united states department health human services panel antiretroviral guidelines recommends use efavirenz combination tenofoviremtricitabine truvada one preferred nnrtibased regimens adults efavirenz also used combination antiretroviral agents part expanded postexposure prophylaxis regimen reduce risk hiv infection people exposed significant risk eg needlestick injuries certain types unprotected sex efavirenz safe use first trimester efavirenz passes breast milk breastfed infants may exposed people taken medication experienced allergic reaction avoid taking efavirenz dosages hypersensitivity reactions include syndrome toxic skin eruptions erythema neuropsychiatric effects common adverse effects include disturbed sleep including nightmares insomnia disrupted sleep daytime fatigue dizziness headaches vertigo blurred vision anxiety cognitive impairment including fatigue confusion memory concentration problems depression including suicidal people experience rash nausea may use efavirenz produce false positive result urine tests efavirenz may lengthen qt interval used people risk torsades de efavirenz may cause convulsions adult pediatric populations history efavirenz broken liver enzymes belong cytochrome system include efavirenz substrate enzymes decrease metabolism drugs require however efavirenz also induces enzymes means enzyme activity enhanced metabolism drugs broken people taking efavirenz drugs metabolized enzymes might need dose drugs increased decreased one group drugs efavirenz affects protease inhibitors used hivaids efavirenz lower blood levels protease inhibitors including amprenavir atazanavir lowered levels protease inhibitors may effective people taking drugs means virus causes hivaids wont stopped replicating may become resistant protease inhibitor efavirenz also affects antifungal drugs used fungal infections urinary tract infections similar effect seen protease inhibitors efavirenz lowers blood levels antifungal drugs like voriconazole itraconazole ketoconazole result lowered levels antifungal drugs may effective people taking drugs means fungi cause infection may become resistant antifungal efavirenz falls nnrti class antiretrovirals nucleoside nonnucleoside rtis inhibit target reverse transcriptase enzyme essential viral enzyme transcribes viral rna dna unlike nucleoside rtis bind enzymes active site nnrtis act allosterically binding distinct site away active site known nnrti pocket efavirenz effective pocket reverse transcriptase different structure confers intrinsic resistance nnrti nnrtis bind within pocket viral strains resistant efavirenz usually also resistant nnrtis nevirapine delavirdine common mutation observed efavirenz treatment also observed nucleoside reversetranscriptase inhibitors nrtis efavirenz different binding targets crossresistance unlikely true regard efavirenz protease mechanism efavirenz neuropsychiatric adverse effects efavirenz appears neurotoxicity possibly interfering mitochondrial function may turn possibly caused inhibiting creatine kinase also possibly disrupting mitochondrial membranes interfering nitric oxide neuropsychiatric adverse effects may mediated cannabinoid receptors activity receptor efavirenz interacts many cns receptors neuropsychiatric adverse effects efavirenz chemically described empirical formula efavirenz white slightly pink crystalline powder molecular mass gmol practically insoluble water Âµgml efavirenz approved fda september february fda approved generic tablet formulation produced late thailands government pharmaceutical organization gpo announced produce efavirenz receiving efavirenz code name dmp discovered du pont pharma european countries set receive license manufacturing efavirenz may onemonth supply mg tablets costs approximately july merck provided efavirenz certain developing countries countries largely affected hiv per emerging countries opted purchase indian thailand onemonth supply efavirenz truvada june cost baht social program patients afford medication thailand produce efavirenz domestically government pharmaceutical organization product costs baht per bottle thirty mg tablets imported version thailand retails baht per bottle gpo devote percent manufacturing capacity make million efavirenz pills allowing serve export markets well domestic philippines alone order bottles efavirenz million south africa license granted generics giant aspen pharmacare manufacture distribute subsaharan africa costeffective antiretroviral abuse efavirenz crushing smoking tablets supposed hallucinogenic dissociative effects reported south africa used mixture known whoonga efavirenz marketed various jurisdictions brand names adiva avifanz efamat efatec efavir efavirenz efcure eferven efrin erige estiva evirenz filginase stocrin sulfina v sustiva virorrever combination efavirenz tenofovir emtricitabine marketed various jurisdictions brand names atripla atroiza citenvir oditec teevir trustiva viraday combination efavirenz tenofovir lamivudine marketed brand name httpsenwikipediaorgwikiefavirenz